Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.65
-0.02 (-0.30%)
Dec 31, 2025, 4:00 PM EST - Market closed
Evolus Market Cap
Evolus has a market cap or net worth of $431.05 million as of December 31, 2025. Its market cap has decreased by -40.86% in one year.
Market Cap
431.05M
Enterprise Value
542.42M
1-Year Change
-40.86%
Ranking
Category
Stock Price
$6.65
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $431.05M, an increase of 58.87%. That is a compound annual growth rate of 6.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 431.05M | -38.34% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |